Page last updated: 2024-11-05

4-nitroanisole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitroanisole: dye intermediate; organic synthesis; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-nitroanisole : A member of the class of 4-nitroanisoles that is anisole in which one the hydrogen meta to the methoxy group is replaced by a nitro group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7485
CHEMBL ID57537
CHEBI ID1911
SCHEMBL ID6918525
SCHEMBL ID492221
SCHEMBL ID14406394
MeSH IDM0046765

Synonyms (55)

Synonym
nsc 5507
ai3-00189
ccris 2321
einecs 202-825-3
4-methoxynitrobenzene
wln: wnr do1
p-methoxynitrobenzene
benzene, 1-methoxy-4-nitro-
nitroanisole
nsc-5507
anisole, p-nitro-
1-methoxy-4-nitrobenzene
p-nitroanisol
nsc5507
inchi=1/c7h7no3/c1-11-7-4-2-6(3-5-7)8(9)10/h2-5h,1h
CHEBI:1911 ,
4-nitrophenyl methyl ether
STK372693
p-nitroanisole
4-nitroanisole
C07555
100-17-4
4-nitroanisole, 97%
CHEMBL57537
N0126
AKOS000121613
1-methoxy-4-nitro-benzene
g989z7wolh ,
unii-g989z7wolh
SCHEMBL6918525
FT-0619198
PS-5781
4-methoxy-1-nitrobenzene
AE-562/40237372
4-nitro-1-methoxybenzene
p-nitrobenzene methyl ether
4-nitromethoxybenzene
nitroanisole, p-
methyl p-nitrophenyl ether
p-nitroanisole [mi]
methyl 4-nitrophenyl ether
p-nitromethoxybenzene
AB01095048-03
4-methoxy-nitrobenzene
4-nitroanisol
DTXSID9059208
SCHEMBL492221
SCHEMBL14406394
mfcd00007327
4-nitroanisole, analytical standard
F0001-0010
NCGC00340123-01
Q27105525
EN300-15566
Z31131411

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" In soil, successive replacement of -NO2 by -NH2 in DNAN enhanced irreversible sorption and reduced bioavailability under oxic conditions."( Environmental fate of 2,4-dinitroanisole (DNAN) and its reduced products.
Ampleman, G; Deschamps, S; Halasz, A; Hawari, J; Monteil-Rivera, F; Paquet, L; Perreault, NN; Radovic-Hrapovic, Z; Thiboutot, S, 2015
)
0.42
" The bioavailability and bioaccumulative potential of the insensitive munitions compound 2,4-dinitroanisole (DNAN) to Eisenia fetida was assessed in soils with different geochemical characteristics."( Accumulation of 2,4-dinitroanisole in the earthworm Eisenia fetida from chemically spiked and aged natural soils.
Bednar, AJ; Brasfield, SM; Chappell, MA; Coleman, JG; Harmon, AR; Lotufo, GR; Russell, AL; Smith, JC, 2016
)
0.43
" Multiple components/phases that vary among different soil types and affect the bioavailability of the MC, however, hinder the ability to separate the effects of soil characteristics from the MC chemical properties on the resulting plant bioconcentration."( Bioconcentration factors and plant-water partition coefficients of munitions compounds in barley.
Allen, HE; Di Toro, DM; Kuo, DTF; Torralba-Sanchez, TL, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
4-nitroanisolesAny member of the class of mononitroanisoles in which the nitro group is situated para to the methoxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID23978Capacity ratio (log k'w)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID189498Rate of O-Dealkylation by liver microsomes in rats induced with PB; Rates are expressed as pmol of product per 30 min per mg of protein1980Journal of medicinal chemistry, Aug, Volume: 23, Issue:8
Metabolism of 6-substituted benzo[a]pyrene derivatives: O-dealkylation and regiospecificity in aromatic hydroxylation.
AID189497Rate of O-Dealkylation by liver microsomes in rats induced with 3-MC; Rates are expressed as pmol of product per 30 min per mg of protein1980Journal of medicinal chemistry, Aug, Volume: 23, Issue:8
Metabolism of 6-substituted benzo[a]pyrene derivatives: O-dealkylation and regiospecificity in aromatic hydroxylation.
AID23714Partition coefficient (logP)1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID203473Binding constant against bovine serum albumin1988Journal of medicinal chemistry, Oct, Volume: 31, Issue:10
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (83)

TimeframeStudies, This Drug (%)All Drugs %
pre-199039 (46.99)18.7374
1990's27 (32.53)18.2507
2000's9 (10.84)29.6817
2010's7 (8.43)24.3611
2020's1 (1.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.73 (24.57)
Research Supply Index4.51 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index61.86 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other89 (98.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]